IP Library Assignment 067680/0956
Patent Assignment
Reel/Frame 067680/0956

Change of Address

Recorded: 2024-06-10 Pages: 6
Assignor
MIRUM PHARMACEUTICALS, INC.
Executed: 2024-06-05
Assignee
MIRUM PHARMACEUTICALS, INC.
989 E HILLSDALE BLVD., SUITE 300, FOSTER CITY, CALIFORNIA, 94404
Covered Properties (17)
Genotype and Dose-Dependent Response to an Asbti in Patients with Bile Salt Export Pump Deficiency
Application: 17/430,125 →
Publication: US 2022/0133738
Methods for Increasing Growth in Pediatric Subjects Having Cholestatic Liver Disease
Application: 17/430,168 →
Publication: US 2022/0152022
Methods for Treating Cholestasis
Application: 17/430,210 →
Publication: US 2022/0160726
Pharmaceutical Compositions Comprising 2,3,4,5-Tetrahydrobenzothiepin- 1,1-Dioxide Derivatives and the Use Thereof
Application: 63/467,823 →
Apical Sodium-Dependent Transporter Inhibitor Compositions
Application: 17/973,194 →
Publication: US 2023/0181527
METHODS OF DOSING OF APICAL SODIUM-DEPENDENT BILE ACID TRANSPORTER INHIBITORS (ASBTIs)
Application: 17/972,909 →
Publication: US 2023/0138455
Treatment with Ileal Bile Acid Transporter (Ibat) Inhibitors for Increased Event-Free Survival (Efs)
Application: 17/981,033 →
Publication: US 2023/0190743
Pharmaceutical Compositions Comprising Maralixibat and Uses Thereof
Application: 18/377,216 →
Publication: US 2025/0114310
Methods for Treating Progressive Familial Intrahepatic Cholestasis
Application: 63/471,291 →
Methods for Treating Progressive Familial Intrahepatic Cholestasis
Application: 63/522,355 →
Maralixibat Solid Forms, Intermediates and Processes of Making Same
Application: 18/368,041 →
Publication: US 2024/0116891
Methods for Treating Progressive Familial Intrahepatic Cholestasis
Application: 18/382,636 →
Publication: US 2024/0173317
Methods for Treating Cholestasis
Application: 18/417,725 →
Publication: US 2024/0189308
Methods for Treating Cholestasis
Application: 18/423,029 →
Publication: US 2024/0207260
Methods for Treating Cholestasis
Application: 16/994,368 →
Publication: US 2020/0375989
Methods for Treating Cholestasis
Application: 17/554,588 →
Publication: US 2022/0105092
Methods for Treating Cholestasis
Application: 17/960,669 →
Publication: US 2023/0190742
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Dec 9, 2020
From: MIRUM PHARMACEUTICALS, INC.
To: MULHOLLAND SA LLC
Reel/Frame 054598/0910 →
Assignment of Assignor's Interest Sep 22, 2021
From: JAECKLIN, THOMAS
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 057565/0284 →
Assignment of Assignor's Interest Sep 22, 2021
From: JAECKLIN, THOMAS
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 057565/0748 →
Assignment of Assignor's Interest Sep 22, 2021
From: JAECKLIN, THOMAS
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 057565/0371 →
Assignment of Assignor's Interest Sep 22, 2021
From: JAECKLIN, THOMAS
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 057565/0164 →
Assignment of Assignor's Interest Nov 9, 2021
From: DORENBAUM, ALEJANDRO
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 058063/0200 →
Assignment of Assignor's Interest Dec 6, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 058320/0798 →
Assignment of Assignor's Interest Dec 6, 2021
From: DORENBAUM, ALEJANDRO
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058311/0209 →
Assignment of Assignor's Interest Dec 10, 2021
From: DORENBAUM, ALEJANDRO
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058358/0210 →
Assignment of Assignor's Interest Dec 20, 2021
From: JAECKLIN, THOMAS
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 058429/0119 →
Assignment of Assignor's Interest Dec 20, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 058548/0790 →
Assignment of Assignor's Interest Dec 20, 2021
From: DORENBAUM, ALEJANDRO
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058429/0199 →
Assignment of Assignor's Interest May 9, 2022
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 059907/0483 →
Change of Address Jul 1, 2022
From: MIRUM PHARMACEUTICALS, INC.
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 060559/0428 →
Assignment of Assignor's Interest Oct 5, 2022
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 061325/0067 →
Assignment of Assignor's Interest Oct 5, 2022
From: DORENBAUM, ALEJANDRO
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 061324/0980 →
Assignment of Assignor's Interest Oct 5, 2022
From: JAECKLIN, THOMAS
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 061325/0016 →
Release of Security Interest Apr 20, 2023
From: MULHOLLAND SA LLC
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 063383/0795 →
Assignment of Assignor's Interest May 4, 2023
From: PEETZ, CHRISTOPHER
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 063541/0158 →
Assignment of Assignor's Interest Jul 10, 2023
From: JAECKLIN, THOMAS
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 064923/0174 →
Assignment of Assignor's Interest Jul 10, 2023
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 064197/0972 →
Assignment of Assignor's Interest Jul 21, 2023
From: GARNER, WILL; VIG, PAMELA
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 064340/0611 →
Assignment of Assignor's Interest Jul 25, 2023
From: VIG, PAMELA
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 064376/0069 →
Confirmation of Patent Ownership Jul 25, 2023
From: JNG PHARMACEUTICAL CONSULTING INC.
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 064375/0577 →
Assignment of Assignor's Interest Jul 25, 2023
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: MIRUM PHARMACEUTICALS, INC.
Reel/Frame 064376/0667 →